These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 13817358)

  • 1. [Development of chemotherapy of infectious diseases in the past 30 years and the future prospects for chemotherapy of cancer].
    DOMAGK G
    Wien Med Wochenschr; 1960 Feb; 110():131-4. PubMed ID: 13817358
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological response modifiers in the treatment of cancer and infectious diseases.
    Rusthoven JJ
    Cancer Cells; 1991 Jun; 3(6):243-4. PubMed ID: 1911038
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies. The future is now. Introduction.
    Mueller KL
    Science; 2013 Sep; 341(6151):1191. PubMed ID: 24031010
    [No Abstract]   [Full Text] [Related]  

  • 4. Modern chemotherapy of infectious diseases; implications and significance.
    FELDMAN WH
    Dis Chest; 1954 Jul; 26(1):1-14. PubMed ID: 13173334
    [No Abstract]   [Full Text] [Related]  

  • 5. [Optimization of therapy. News in oncology and in management of infectious diseases].
    Chirurg; 1999 Jun; 70(6 Suppl):1-4. PubMed ID: 10416078
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-idiotypic antibodies in therapy: current status and prospects].
    Perosa F; Dammacco F
    Ric Clin Lab; 1989; 19 Suppl 2():69-85. PubMed ID: 2694309
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.
    Baden LR; Swaminathan S; Angarone M; Blouin G; Camins BC; Casper C; Cooper B; Dubberke ER; Engemann AM; Freifeld AG; Greene JN; Ito JI; Kaul DR; Lustberg ME; Montoya JG; Rolston K; Satyanarayana G; Segal B; Seo SK; Shoham S; Taplitz R; Topal J; Wilson JW; Hoffmann KG; Smith C
    J Natl Compr Canc Netw; 2016 Jul; 14(7):882-913. PubMed ID: 27407129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designer probiotics for the prevention and treatment of human diseases.
    Chua KJ; Kwok WC; Aggarwal N; Sun T; Chang MW
    Curr Opin Chem Biol; 2017 Oct; 40():8-16. PubMed ID: 28478369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious diseases.
    TILLETT WS
    Annu Rev Med; 1953; 4():1-20. PubMed ID: 13105265
    [No Abstract]   [Full Text] [Related]  

  • 10. [What has been ascertained in therapy in 2015?].
    Haller H
    Internist (Berl); 2015 Dec; 56(12):1345. PubMed ID: 26566995
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy and basic principles of general therapy of infectious diseases].
    BILIBIN AF
    Sov Med; 1957 Sep; 21(9):3-12. PubMed ID: 13519227
    [No Abstract]   [Full Text] [Related]  

  • 12. Holobionts: emerging strategy for interventions against infectious diseases, metabolic disorders & cancer.
    Singh Y; Hasnain SE
    Indian J Med Res; 2014 Jul; 140(1):11-4. PubMed ID: 25222772
    [No Abstract]   [Full Text] [Related]  

  • 13. Highlights of the international symposium on immunotherapeutic prospects of infectious diseases.
    Masihi KN
    Nat Immun Cell Growth Regul; 1991; 10(4):185-95. PubMed ID: 1896053
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problems and prospects of the development of pediatric infectious disease services in the USSR].
    Vaganov NN
    Pediatriia; 1989; (2):5-8. PubMed ID: 2726366
    [No Abstract]   [Full Text] [Related]  

  • 15. [The B.Q.X. new anti-infectious chemotherapy].
    DE MATTIA R
    Minerva Med; 1948 Aug; 39(32):134. PubMed ID: 18879438
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new approach to immunotherapy: the transfer factor].
    Di Padova F
    Minerva Med; 1979 May; 70(25):1773-85. PubMed ID: 379697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in cellular therapy: 6th International Symposium on the clinical use of cellular products, March 24 and 25, 2011, Erlangen, Germany.
    Ullrich E; Bosch J; Aigner M; Voelkl S; Kroeger I; Hoffmann P; Kreutz M; Dudziak D; Gerbitz A
    Cancer Immunol Immunother; 2012 Mar; 61(3):433-43. PubMed ID: 22200930
    [No Abstract]   [Full Text] [Related]  

  • 18. The interferons--Part 1.
    Freeman PR
    Am Pharm; 1994 May; NS34(5):24-6. PubMed ID: 7518644
    [No Abstract]   [Full Text] [Related]  

  • 19. The past, present, and future uses of liposomes in treating infectious diseases.
    Wasan KM; Lopez-Berestein G
    Immunopharmacol Immunotoxicol; 1995 Feb; 17(1):1-15. PubMed ID: 7759766
    [No Abstract]   [Full Text] [Related]  

  • 20. Conference scene--active immunotherapeutics forum: meeting highlights.
    Lisziewicz J
    Immunotherapy; 2009 Sep; 1(5):743-8. PubMed ID: 20636019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.